Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Robust and stable immediate release formulation of candesartan cilexetil , bcs class iv drug and its statistical optimization

  • At: 2009 FIP Congress in Istanbul (Turkey)
  • Type: Poster
  • By: KOHLI, Kanchan (D/o Pharmaceutics, F/o Pharmacy, Jamia Hamdard University, New Delhi, India)
  • Co-author(s): Kumar, Ramesh (D/o Pharmaceutics, F/o Pharmacy, Jamia Hamdard University, NEW DELHI, India)
    Garg, Abhinav (D/o Pharmaceutics, F/o Pharmacy, Jamia Hamdard University, NEW DELHI, India)
    Kumar, Anoop (D/o Pharmaceutics, F/o Pharmacy, Jamia Hamdard University, NEW DELHI, India)
  • Abstract:

    Candesartan cilexetil (C.C), a selective AT I Antagonist indicated for Hypertension. This potent prodrug poses great challenges to formulators as it falls in Bio classification system (BCS) class IV and hence has a limitation of poor bioavailability and bioequivalence. Present research work aimed at developing a statistically optimized immediate..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses